OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers
Clinical Study of OPTI-FREE® PureMoist® for Presbyopic Contact Lens Wearers
Sponsor: Alcon, a Novartis Company
Listed as NCT02965820, this NA trial focuses on Presbyopia and remains completed. Sponsored by Alcon, a Novartis Company, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Aug 2018 — Jan 2021 [monthly]
Completed NA
-
Jul 2018 — Aug 2018 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Completed NA
-
May 2018 — Jun 2018 [monthly]
Completed NA
-
Jun 2017 — May 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alcon, a Novartis Company
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.